Aerovate Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $136 |
Gross Profit | -28 | -28 | 108 |
EBITDA | -26,137 | -24,590 | -22,038 |
EBIT | -26,165 | -24,618 | -22,066 |
Net Income | -24,775 | -23,186 | -20,413 |
Net Change In Cash | 0 | 0 | 136 |
Free Cash Flow | -20,433 | -23,673 | -14,864 |
Cash | 31,069 | 9,122 | 23,491 |
Basic Shares | 28,756 | 27,795 | 27,695 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -96 | -68 | -15 | -1 |
EBITDA | -81,313 | -53,169 | -23,007 | -8,888 |
EBIT | -81,409 | -53,237 | -23,022 | -8,889 |
Net Income | -75,521 | -51,511 | -22,963 | -9,039 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -56,920 | -39,317 | -27,580 | -7,859 |
Cash | 23,491 | 22,397 | 54,197 | 4,573 |
Basic Shares | 26,331 | 24,472 | 24,410 | 24,410 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.56 |
2024-06-30 | -$0.86 |
2024-03-31 | -$0.83 |
2023-12-31 | -$0.74 |
